For decades, organizations have viewed mental health as a reactive challenge—an issue to be addressed only when it becomes a crisis. Traditional employee assistance programs (EAPs) were designed with ...
New program pairs microdoses of GLP-1 medication with Noom’s powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I examine the rising trend of so-called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback